Jump to content

Talk:Trigeminal neuralgia

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by LjL (talk | contribs) at 00:50, 29 April 2023 (→‎Pregabalin contradiction?: Reply). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Please add {{WikiProject banner shell}} to this page and add the quality rating to that template instead of this project banner. See WP:PIQA for details.
WikiProject iconDentistry Start‑class Mid‑importance
WikiProject iconThis article is supported by WikiProject Dentistry. If you want to participate and/or join, please visit the project page, or ask questions on the project talk page.
StartThis article has been rated as Start-class on Wikipedia's content assessment scale.
MidThis article has been rated as Mid-importance on the project's importance scale.
Please add {{WikiProject banner shell}} to this page and add the quality rating to that template instead of this project banner. See WP:PIQA for details.
WikiProject iconMedicine: Dermatology / Neurology C‑class Mid‑importance
WikiProject iconThis article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.
CThis article has been rated as C-class on Wikipedia's content assessment scale.
MidThis article has been rated as Mid-importance on the project's importance scale.
Taskforce icon
This article is supported by the Dermatology task force.
Taskforce icon
This article is supported by the Neurology task force (assessed as High-importance).

Pregabalin contradiction?

"Antidepressant medications, such as amitriptyline have shown good efficacy in treating trigeminal neuralgia, especially if combined with an anti-convulsant drug such as pregabalin.[27]"

This is in contradiction with the article on Pregabalin:

"Pregabalin is not recommended for certain other types of neuropathic pain such as trigeminal neuralgia[31] and its use in cancer-associated neuropathic pain is controversial.[31]" (https://en.wikipedia.org/wiki/Pregabalin)

What gives?

Sobeita (talk) 20:03, 23 July 2018 (UTC)[reply]

By now the statement is no longer there so I can't check the source either, but pregabalin is commonly used as a second-line TN treatment when things like carbamazepine fail, and this is mentioned in a number of papers, so should someone want to add the statement again, I am confident there is a lot to (not) back it. LjL (talk) 00:50, 29 April 2023 (UTC)[reply]

#humanintellectualproperty

  1. humanrightswatchlegal Jacquelene L. Corbett (talk) 01:47, 13 January 2019 (UTC)[reply]

Lancet neurology

doi:10.1016/S1474-4422(20)30233-7 JFW | T@lk 15:01, 19 August 2020 (UTC)[reply]

NEJM

doi:10.1056/NEJMra1914484 JFW | T@lk 22:18, 19 August 2020 (UTC)[reply]

Thanks for this, interesting for both my job and the article. - After briefly reading this article I did not substantial improvements that need to be made. Will work on it soon. PainProf (talk) 15:25, 20 August 2020 (UTC)[reply]

Epidemiology cited wrongly

Hi, The epidemiology of trigeminal neuralgia is wrongly cited from the source. Instead of 1 in 8000 per year it should be 12 in 100000 a year.